HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-AUG-16 5T1T TITLE IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 160-460; COMPND 5 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF21 KEYWDS INASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.O.FISCHMANN REVDAT 4 04-OCT-23 5T1T 1 REMARK REVDAT 3 22-NOV-17 5T1T 1 REMARK REVDAT 2 28-JUN-17 5T1T 1 JRNL REVDAT 1 03-MAY-17 5T1T 0 JRNL AUTH G.F.SMITH,M.D.ALTMAN,B.ANDRESEN,J.BAKER,J.D.BRUBAKER,H.CHEN, JRNL AUTH 2 Y.CHEN,M.CHILDERS,A.DONOFRIO,H.FERGUSON,C.FISCHER, JRNL AUTH 3 T.O.FISCHMANN,C.GIBEAU,A.HICKS,S.JIN,S.KATTAR, JRNL AUTH 4 M.A.KLEINSCHEK,E.LECCESE,C.LESBURG,C.LI,J.LIM,D.LIU, JRNL AUTH 5 J.K.F.MACLEAN,F.MANSOOR,L.Y.MOY,E.F.MULROONEY,A.S.NECHEVA, JRNL AUTH 6 J.PRESLAND,L.RAKHILINA,R.YANG,L.TORRES,J.ZHANG-HOOVER, JRNL AUTH 7 A.NORTHRUP JRNL TITL IDENTIFICATION OF QUINAZOLINE BASED INHIBITORS OF IRAK4 FOR JRNL TITL 2 THE TREATMENT OF INFLAMMATION. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 2721 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28501511 JRNL DOI 10.1016/J.BMCL.2017.04.050 REMARK 2 REMARK 2 RESOLUTION. 2.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 59217 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 3032 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.56 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4355 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2311 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4139 REMARK 3 BIN R VALUE (WORKING SET) : 0.2313 REMARK 3 BIN FREE R VALUE : 0.2284 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.96 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 216 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8993 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.02 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.35980 REMARK 3 B22 (A**2) : 11.81470 REMARK 3 B33 (A**2) : -6.45500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.85770 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.311 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.284 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.201 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 18087 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 32664 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 4061 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 267 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 2639 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 18087 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1199 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 18391 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.06 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5T1T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000223477. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS (VERSION SEPTEMBER 2 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC, SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59599 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.335 REMARK 200 RESOLUTION RANGE LOW (A) : 38.620 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2NRU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.80 TO 2.0 M SODIUM MALONATE 0.2 M REMARK 280 SODIUM ACETATE 25 MM HEXAMMINECOBALT(III)CHLORIDE 0.05%W/V REMARK 280 PLURONIC-F-68, PH 6.4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.50000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 69.78000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.50000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 69.78000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 SER A 460 REMARK 465 VAL B 160 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 THR B 223 REMARK 465 GLU B 224 REMARK 465 GLU B 225 REMARK 465 LEU B 226 REMARK 465 LYS B 227 REMARK 465 SER B 336 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 SER B 460 REMARK 465 VAL C 160 REMARK 465 SER C 161 REMARK 465 ASP C 162 REMARK 465 THR C 163 REMARK 465 ALA C 217 REMARK 465 MET C 218 REMARK 465 VAL C 219 REMARK 465 ASP C 220 REMARK 465 LYS C 338 REMARK 465 PHE C 339 REMARK 465 ALA C 340 REMARK 465 GLN C 341 REMARK 465 VAL D 160 REMARK 465 SER D 161 REMARK 465 ASP D 162 REMARK 465 THR D 163 REMARK 465 ALA D 217 REMARK 465 MET D 218 REMARK 465 VAL D 219 REMARK 465 ASP D 220 REMARK 465 ILE D 221 REMARK 465 GLU D 337 REMARK 465 LYS D 338 REMARK 465 PHE D 339 REMARK 465 ALA D 340 REMARK 465 GLN D 341 REMARK 465 SER D 460 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 216 C O CB REMARK 470 ALA A 335 O REMARK 470 ALA A 459 C O CB REMARK 470 ALA B 216 C O CB REMARK 470 ALA B 335 O REMARK 470 GLN B 341 N CB CG CD OE1 NE2 REMARK 470 ALA B 459 C O CB REMARK 470 ALA C 216 O REMARK 470 ILE C 221 N CB CG1 CG2 CD1 REMARK 470 GLU C 337 C O CB CG CD OE1 OE2 REMARK 470 SER C 460 C O CB OG REMARK 470 ALA D 216 O REMARK 470 SER D 336 O REMARK 470 ALA D 459 C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 197 29.96 42.16 REMARK 500 ASN A 207 -10.81 66.09 REMARK 500 SER A 253 -76.41 -85.23 REMARK 500 ASP A 254 76.18 34.52 REMARK 500 ARG A 310 -1.73 75.88 REMARK 500 ASP A 311 49.35 -149.64 REMARK 500 ASP A 329 81.10 67.32 REMARK 500 HIS A 390 49.00 -99.13 REMARK 500 SER B 186 -53.55 -156.84 REMARK 500 ASN B 207 -9.53 69.78 REMARK 500 ASP B 254 -36.50 -29.95 REMARK 500 ARG B 310 -2.27 76.11 REMARK 500 ASP B 311 49.51 -149.14 REMARK 500 ASP B 329 80.73 67.63 REMARK 500 HIS B 390 49.35 -99.14 REMARK 500 PHE C 197 28.82 46.99 REMARK 500 ASN C 206 -113.00 73.45 REMARK 500 ASP C 256 -105.29 -75.32 REMARK 500 ASP C 257 89.85 -9.34 REMARK 500 ARG C 310 -2.18 74.35 REMARK 500 ASP C 311 49.29 -149.13 REMARK 500 ASP C 329 81.10 66.90 REMARK 500 SER C 336 53.68 -141.19 REMARK 500 HIS C 390 48.84 -97.64 REMARK 500 ASN D 206 -115.04 75.22 REMARK 500 ASP D 254 -34.01 -32.54 REMARK 500 ARG D 310 -1.74 76.03 REMARK 500 ASP D 311 49.28 -150.16 REMARK 500 ASP D 329 80.50 67.54 REMARK 500 HIS D 390 48.74 -99.10 REMARK 500 LYS D 417 34.90 -83.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 76P A 9901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 76P B 9901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 76P C 9901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 76P D 9901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5T1S RELATED DB: PDB DBREF 5T1T A 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 DBREF 5T1T B 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 DBREF 5T1T C 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 DBREF 5T1T D 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 SEQRES 1 A 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 A 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 A 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 A 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 A 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 A 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 A 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 A 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 A 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 A 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 A 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 A 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 A 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 A 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 A 301 TPO VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 A 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 A 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 A 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 A 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 A 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 A 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 A 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 A 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 A 301 ALA SER SEQRES 1 B 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 B 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 B 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 B 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 B 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 B 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 B 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 B 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 B 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 B 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 B 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 B 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 B 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 B 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 B 301 TPO VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 B 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 B 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 B 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 B 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 B 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 B 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 B 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 B 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 B 301 ALA SER SEQRES 1 C 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 C 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 C 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 C 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 C 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 C 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 C 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 C 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 C 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 C 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 C 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 C 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 C 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 C 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 C 301 TPO VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 C 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 C 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 C 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 C 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 C 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 C 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 C 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 C 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 C 301 ALA SER SEQRES 1 D 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 D 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 D 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 D 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 D 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 D 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 D 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 D 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 D 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 D 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 D 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 D 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 D 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 D 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 D 301 TPO VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 D 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 D 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 D 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 D 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 D 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 D 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 D 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 D 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 D 301 ALA SER MODRES 5T1T TPO A 342 THR MODIFIED RESIDUE MODRES 5T1T TPO A 345 THR MODIFIED RESIDUE MODRES 5T1T SEP A 346 SER MODIFIED RESIDUE MODRES 5T1T TPO B 342 THR MODIFIED RESIDUE MODRES 5T1T TPO B 345 THR MODIFIED RESIDUE MODRES 5T1T SEP B 346 SER MODIFIED RESIDUE MODRES 5T1T TPO C 342 THR MODIFIED RESIDUE MODRES 5T1T TPO C 345 THR MODIFIED RESIDUE MODRES 5T1T SEP C 346 SER MODIFIED RESIDUE MODRES 5T1T TPO D 342 THR MODIFIED RESIDUE MODRES 5T1T TPO D 345 THR MODIFIED RESIDUE MODRES 5T1T SEP D 346 SER MODIFIED RESIDUE HET TPO A 342 11 HET TPO A 345 11 HET SEP A 346 10 HET TPO B 342 11 HET TPO B 345 11 HET SEP B 346 10 HET TPO C 342 11 HET TPO C 345 11 HET SEP C 346 10 HET TPO D 342 11 HET TPO D 345 11 HET SEP D 346 10 HET 76P A9901 23 HET 76P B9901 23 HET 76P C9901 23 HET 76P D9901 23 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 76P ~{N},~{N}-DIMETHYL-4-(6-NITROQUINAZOLIN-4-YL)OXY- HETNAM 2 76P CYCLOHEXAN-1-AMINE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 8(C4 H10 N O6 P) FORMUL 1 SEP 4(C3 H8 N O6 P) FORMUL 5 76P 4(C16 H20 N4 O3) FORMUL 9 HOH *81(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 THR A 223 CYS A 240 1 18 HELIX 3 AA3 SER A 269 SER A 275 1 7 HELIX 4 AA4 CYS A 276 THR A 280 5 5 HELIX 5 AA5 SER A 284 ASN A 305 1 22 HELIX 6 AA6 LYS A 313 ALA A 315 5 3 HELIX 7 AA7 THR A 351 MET A 355 5 5 HELIX 8 AA8 ALA A 356 ARG A 361 1 6 HELIX 9 AA9 PRO A 366 GLY A 383 1 18 HELIX 10 AB1 LEU A 395 LEU A 397 5 3 HELIX 11 AB2 ASP A 398 ASP A 405 1 8 HELIX 12 AB3 THR A 409 TYR A 413 5 5 HELIX 13 AB4 ASP A 422 LEU A 437 1 16 HELIX 14 AB5 LYS A 440 ARG A 444 5 5 HELIX 15 AB6 ASP A 446 ALA A 459 1 14 HELIX 16 AB7 SER B 169 THR B 177 1 9 HELIX 17 AB8 GLN B 229 CYS B 240 1 12 HELIX 18 AB9 SER B 269 SER B 275 1 7 HELIX 19 AC1 CYS B 276 THR B 280 5 5 HELIX 20 AC2 SER B 284 ASN B 305 1 22 HELIX 21 AC3 LYS B 313 ALA B 315 5 3 HELIX 22 AC4 THR B 351 MET B 355 5 5 HELIX 23 AC5 ALA B 356 ARG B 361 1 6 HELIX 24 AC6 PRO B 366 GLY B 383 1 18 HELIX 25 AC7 LEU B 395 LEU B 397 5 3 HELIX 26 AC8 ASP B 398 ASP B 405 1 8 HELIX 27 AC9 THR B 409 TYR B 413 5 5 HELIX 28 AD1 ASP B 422 LEU B 437 1 16 HELIX 29 AD2 LYS B 440 ARG B 444 5 5 HELIX 30 AD3 ASP B 446 ALA B 459 1 14 HELIX 31 AD4 SER C 169 THR C 177 1 9 HELIX 32 AD5 PRO C 184 GLY C 188 5 5 HELIX 33 AD6 THR C 222 CYS C 240 1 19 HELIX 34 AD7 SER C 269 SER C 275 1 7 HELIX 35 AD8 CYS C 276 THR C 280 5 5 HELIX 36 AD9 SER C 284 ASN C 305 1 22 HELIX 37 AE1 THR C 351 MET C 355 5 5 HELIX 38 AE2 ALA C 356 ARG C 361 1 6 HELIX 39 AE3 PRO C 366 GLY C 383 1 18 HELIX 40 AE4 LEU C 395 LEU C 397 5 3 HELIX 41 AE5 ASP C 398 ASP C 405 1 8 HELIX 42 AE6 THR C 409 TYR C 413 5 5 HELIX 43 AE7 ASP C 422 LEU C 437 1 16 HELIX 44 AE8 LYS C 440 ARG C 444 5 5 HELIX 45 AE9 ASP C 446 SER C 460 1 15 HELIX 46 AF1 SER D 169 THR D 177 1 9 HELIX 47 AF2 PRO D 184 GLY D 188 5 5 HELIX 48 AF3 THR D 223 CYS D 240 1 18 HELIX 49 AF4 SER D 269 SER D 275 1 7 HELIX 50 AF5 CYS D 276 THR D 280 5 5 HELIX 51 AF6 SER D 284 ASN D 305 1 22 HELIX 52 AF7 LYS D 313 ALA D 315 5 3 HELIX 53 AF8 THR D 351 MET D 355 5 5 HELIX 54 AF9 ALA D 356 ARG D 361 1 6 HELIX 55 AG1 PRO D 366 GLY D 383 1 18 HELIX 56 AG2 LEU D 395 LEU D 397 5 3 HELIX 57 AG3 ASP D 398 ASP D 405 1 8 HELIX 58 AG4 THR D 409 TYR D 413 5 5 HELIX 59 AG5 ASP D 422 LEU D 437 1 16 HELIX 60 AG6 LYS D 440 ARG D 444 5 5 HELIX 61 AG7 ASP D 446 ALA D 459 1 14 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LEU A 215 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 GLY A 198 VAL A 205 -1 N GLY A 203 O VAL A 210 SHEET 6 AA1 6 LYS A 191 GLU A 194 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 2 VAL A 343 MET A 344 0 SHEET 2 AA3 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA4 6 HIS B 166 SER B 167 0 SHEET 2 AA4 6 LEU B 248 SER B 252 1 O LEU B 249 N HIS B 166 SHEET 3 AA4 6 CYS B 259 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA4 6 THR B 208 LEU B 215 -1 N LYS B 213 O LEU B 260 SHEET 5 AA4 6 GLY B 198 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA4 6 LYS B 191 GLU B 194 -1 N MET B 192 O VAL B 200 SHEET 1 AA5 2 ILE B 317 LEU B 319 0 SHEET 2 AA5 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA6 2 VAL B 343 MET B 344 0 SHEET 2 AA6 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 SHEET 1 AA7 6 HIS C 166 SER C 167 0 SHEET 2 AA7 6 LEU C 248 SER C 252 1 O LEU C 249 N HIS C 166 SHEET 3 AA7 6 CYS C 259 VAL C 263 -1 O VAL C 261 N LEU C 249 SHEET 4 AA7 6 THR C 208 LEU C 215 -1 N ALA C 211 O TYR C 262 SHEET 5 AA7 6 GLY C 198 VAL C 205 -1 N TYR C 201 O VAL C 212 SHEET 6 AA7 6 LYS C 191 GLU C 194 -1 N MET C 192 O VAL C 200 SHEET 1 AA8 2 HIS C 307 ILE C 308 0 SHEET 2 AA8 2 ARG C 334 ALA C 335 -1 O ARG C 334 N ILE C 308 SHEET 1 AA9 2 ILE C 317 LEU C 319 0 SHEET 2 AA9 2 ALA C 325 ILE C 327 -1 O LYS C 326 N LEU C 318 SHEET 1 AB1 2 VAL C 343 MET C 344 0 SHEET 2 AB1 2 GLU C 363 ILE C 364 -1 O ILE C 364 N VAL C 343 SHEET 1 AB2 6 HIS D 166 SER D 167 0 SHEET 2 AB2 6 LEU D 248 SER D 252 1 O LEU D 249 N HIS D 166 SHEET 3 AB2 6 CYS D 259 VAL D 263 -1 O VAL D 261 N GLY D 250 SHEET 4 AB2 6 THR D 208 LEU D 215 -1 N LYS D 213 O LEU D 260 SHEET 5 AB2 6 GLY D 198 VAL D 205 -1 N TYR D 201 O VAL D 212 SHEET 6 AB2 6 LYS D 191 GLU D 194 -1 N MET D 192 O VAL D 200 SHEET 1 AB3 2 HIS D 307 ILE D 308 0 SHEET 2 AB3 2 ARG D 334 ALA D 335 -1 O ARG D 334 N ILE D 308 SHEET 1 AB4 2 ILE D 317 LEU D 319 0 SHEET 2 AB4 2 ALA D 325 ILE D 327 -1 O LYS D 326 N LEU D 318 SHEET 1 AB5 2 VAL D 343 MET D 344 0 SHEET 2 AB5 2 GLU D 363 ILE D 364 -1 O ILE D 364 N VAL D 343 LINK C TPO A 342 N VAL A 343 1555 1555 1.33 LINK C MET A 344 N TPO A 345 1555 1555 1.33 LINK C TPO A 345 N SEP A 346 1555 1555 1.34 LINK C SEP A 346 N ARG A 347 1555 1555 1.35 LINK C GLN B 341 N TPO B 342 1555 1555 1.34 LINK C TPO B 342 N VAL B 343 1555 1555 1.33 LINK C MET B 344 N TPO B 345 1555 1555 1.34 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.35 LINK C TPO C 342 N VAL C 343 1555 1555 1.34 LINK C MET C 344 N TPO C 345 1555 1555 1.33 LINK C TPO C 345 N SEP C 346 1555 1555 1.34 LINK C SEP C 346 N ARG C 347 1555 1555 1.35 LINK C TPO D 342 N VAL D 343 1555 1555 1.34 LINK C MET D 344 N TPO D 345 1555 1555 1.34 LINK C TPO D 345 N SEP D 346 1555 1555 1.34 LINK C SEP D 346 N ARG D 347 1555 1555 1.35 CISPEP 1 GLU A 392 PRO A 393 0 -2.38 CISPEP 2 GLU B 392 PRO B 393 0 -2.66 CISPEP 3 GLU C 392 PRO C 393 0 -2.54 CISPEP 4 GLU D 392 PRO D 393 0 -2.35 SITE 1 AC1 10 MET A 192 ALA A 211 LYS A 213 TYR A 262 SITE 2 AC1 10 VAL A 263 MET A 265 ASP A 272 LEU A 318 SITE 3 AC1 10 SER A 328 HOH A0002 SITE 1 AC2 11 MET B 192 ALA B 211 LYS B 213 VAL B 246 SITE 2 AC2 11 TYR B 262 VAL B 263 MET B 265 ASP B 272 SITE 3 AC2 11 LEU B 318 SER B 328 HOH B0004 SITE 1 AC3 9 MET C 192 ALA C 211 LYS C 213 VAL C 246 SITE 2 AC3 9 TYR C 262 VAL C 263 MET C 265 ASP C 272 SITE 3 AC3 9 LEU C 318 SITE 1 AC4 11 MET D 192 GLY D 193 ALA D 211 LYS D 213 SITE 2 AC4 11 VAL D 246 TYR D 262 VAL D 263 MET D 265 SITE 3 AC4 11 ASP D 272 LEU D 318 HOH D0002 CRYST1 143.000 139.560 87.340 90.00 124.45 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006993 0.000000 0.004797 0.00000 SCALE2 0.000000 0.007165 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013885 0.00000